Este sitio está destinado solo a profesionales de la salud residentes en México

Buscar

Menu

Close

Iniciar sesiónCerrar sesión

Medicamentos

EspecialidadesAtención PrimariaCardiologíaCOVID-19DermatologíaEnfermedades RarasGinecologíaHematologíaHospitalesNeurologíaVacunas: Herramientas Digitales de VacunaciónOncologíaVacunas: Herramientas Digitales de VacunaciónPsiquiatríaReumatologíaVacunasVacunas: Herramientas Digitales de Vacunación

Eventos

Actualización MédicaTecnología en la medicinaCasos ClínicosVideos y PodcastsCentro de Entrenamiento PfizerNoticias y Blog Conecta SaludBibliotecas MédicasContáctenos
null

Menu

Close

Acerca de Braftovi (encorafenib) + Mektovi (binimetinib)Acerca de Braftovi (encorafenib) + Mektovi (binimetinib)Generalidades del melanomaMecanismo de AcciónEstudio COLUMBUSDosis y AdministraciónDosingRecommended dosing scheduleRecommended dose modificationsDosing and application FAQRecursos de ApoyoRecursos de ApoyoEventosMaterialesVideosInserto de FármacoInserto de FármacoInserto de Fármaco
Recommended dose modifications

This site is an example site, the pages, content, layout and components used are suggested as best practice. Content and pages should be changed according to brand needs and should be aligned to the agreed country information architecture template.

H3 Heading

This site is an example site, the pages, content, layout and components used are suggested as best practice. Content and pages should be changed according to brand needs and should be aligned to the agreed country information architecture template.

This site is an example site, the pages, content, layout and components used are suggested as best practice. Content and pages should be changed according to brand needs and should be aligned to the agreed country information architecture template.

H4 (Desktop)H4 (Mobile)

This site is an example site, the pages, content, layout and components used are suggested as best practice. Content and pages should be changed according to brand needs and should be aligned to the agreed country information architecture template.

Paragraph text leading to bullet points: 

  • Bullet points facilisis nibh. Curabitur venenatis sed enim eget molestie.
  • ​​​​​​​Maecenas iaculis non quam at hendrerit. Integer at bibendum sapien. Suspendisse malesuada, ipsum vitae interdum tempus, nunc nisi ultrices arcu.
  • ​​​​​​​Et tempus massa risus quis metus.  
H4 (Desktop)H4 (Mobile)

This site is an example site, the pages, content, layout and components used are suggested as best practice. Content and pages should be changed according to brand needs and should be aligned to the agreed country information architecture template.

Paragraph text leading to bullet points: 

  • Bullet points facilisis nibh. Curabitur venenatis sed enim eget molestie.
  • ​​​​​​​Maecenas iaculis non quam at hendrerit. Integer at bibendum sapien. Suspendisse malesuada, ipsum vitae interdum tempus, nunc nisi ultrices arcu.
  • ​​​​​​​Maecenas iaculis non quam at hendrerit. Integer at bibendum sapien. Suspendisse malesuada, ipsum vitae interdum tempus, nunc nisi ultrices arcu.
  • ​​​​​​​Et tempus massa risus quis metus.  
Explore more Header of this CTA card goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim…

 Button Header of this CTA card goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim…

 Button
Reference:Reference text - Paragraph text - Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce bibendum felis id turpis interdum eleifend. Ut egestas eleifend nunc sed mollis. 
Dosing Header of this CTA card goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim…

 Button Header of this card goes here

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim…

 Button
XXX-XX- XXX-1234.Dec 2021
Cuenta PfizerPro

Este sitio web es traído a usted por PfizerPro México

 

©Copyright, 2024. Pfizer, S.A. de C.V. Todos los derechos reservados.

 

Aprobación SSA: 223300202C8198
PP-UNP-MEX-0191

 
Usted está saliendo de PfizerPro.   
​​​​​​​ ​
​​​​​​​Usted está saliendo de PfizerPro.​​​​​​​​​​​​​​

​​​​​​​​​​​​​​​​​​​​​